Literature DB >> 12097602

A chimeric human T-cell lymphotropic virus type 1 with the envelope glycoprotein of Moloney murine leukemia virus is infectious for murine cells.

Frédéric Delebecque1, Karin Pramberger, Marie-Christine Prévost, Michel Brahic, Frédéric Tangy.   

Abstract

We constructed a chimeric human T-cell lymphotropic virus type 1 (HTLV-1) provirus in which the original envelope precursor sequence was replaced by that of ecotropic Moloney murine leukemia virus (Mo-MuLV). Chimeric particles produced by transient transfection of this chimeric provirus were infectious for murine cells, such as NIH 3T3 fibroblasts, lymphoid EL4 cells, and primary CD4(+) T lymphocytes, whereas HTLV-1 particles were not. The infectivity of chimeric particles increased 10 times when the R peptide located at the carboxy terminus of the MuLV envelope glycoprotein was deleted. Primary murine CD4(+) T lymphocytes, infected by the Delta R chimeric virus, released particles that could spread the infection to other naive murine lymphoid cells. This chimeric virus, with the Mo-MuLV envelope glycoprotein and the replication characteristics of HTLV-1, should be useful in studying the pathogenesis of HTLV-1 in a mouse model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097602      PMCID: PMC136376          DOI: 10.1128/jvi.76.15.7883-7889.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): provirus expression, persistence, and humoral and cellular immune responses.

Authors:  M Kazanji; A Ureta-Vidal; S Ozden; F Tangy; B de Thoisy; L Fiette; A Talarmin; A Gessain; G de Thé
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Improved transmission electron microscopy (TEM) of cultured cells through a "floating sheet" method.

Authors:  J R Arnold; P J Boor
Journal:  J Ultrastruct Mol Struct Res       Date:  1986-01

3.  Rapid cell culture assay technic for murine leukaemia viruses.

Authors:  R H Bassin; N Tuttle; P J Fischinger
Journal:  Nature       Date:  1971-02-19       Impact factor: 49.962

4.  Human T-cell leukemia virus type I: induction of syncytia and inhibition by patients' sera.

Authors:  K Nagy; P Clapham; R Cheingsong-Popov; R A Weiss
Journal:  Int J Cancer       Date:  1983-09-15       Impact factor: 7.396

5.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

6.  Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay.

Authors:  K Okuma; M Nakamura; S Nakano; Y Niho; Y Matsuura
Journal:  Virology       Date:  1999-02-15       Impact factor: 3.616

7.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Oral transmission of human T-cell leukemia virus type-I into a common marmoset (Callithrix jacchus) as an experimental model for milk-borne transmission.

Authors:  K Yamanouchi; K Kinoshita; R Moriuchi; S Katamine; T Amagasaki; S Ikeda; M Ichimaru; T Miyamoto; S Hino
Journal:  Jpn J Cancer Res       Date:  1985-06

9.  Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.

Authors:  M Seiki; S Hattori; Y Hirayama; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Genomic structure of HTLV (human T-cell leukemia virus): detection of defective genome and its amplification in MT-2 cells.

Authors:  N Kobayashi; H Konishi; H Sabe; K Shigesada; T Noma; T Honjo; M Hatanaka
Journal:  EMBO J       Date:  1984-06       Impact factor: 11.598

View more
  13 in total

Review 1.  Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.

Authors:  Michael D Lairmore; Lee Silverman; Lee Ratner
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

2.  A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness.

Authors:  Mary Jane Potash; Wei Chao; Galina Bentsman; Nicolae Paris; Manisha Saini; Jadwiga Nitkiewicz; Paula Belem; Leroy Sharer; Andrew I Brooks; David J Volsky
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-23       Impact factor: 11.205

3.  Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice.

Authors:  Saifur Rahman; Sharrón L Manuel; Zafar K Khan; Brian Wigdahl; Edward Acheampong; Frederic Tangy; Pooja Jain
Journal:  J Immunol       Date:  2010-04-09       Impact factor: 5.422

4.  Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection.

Authors:  Saifur Rahman; Zafar K Khan; Brian Wigdahl; Stephen R Jennings; Frederic Tangy; Pooja Jain
Journal:  J Immunol       Date:  2010-11-29       Impact factor: 5.422

5.  Reciprocal functional pseudotyping of HIV-1 and HTLV-1 viral genomes by the heterologous counterpart envelope proteins.

Authors:  Zachary Klase; Kuan-Teh Jeang
Journal:  Virology       Date:  2013-06-05       Impact factor: 3.616

Review 6.  Pathogenesis and treatment of human T-cell leukemia virus infection.

Authors:  Lee Ratner
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

7.  Construction and characterization of a human T-cell lymphotropic virus type 3 infectious molecular clone.

Authors:  Sébastien Alain Chevalier; Nga Ling Ko; Sara Calattini; Adeline Mallet; Marie-Christine Prévost; Kylene Kehn; John N Brady; Fatah Kashanchi; Antoine Gessain; Renaud Mahieux
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

8.  In vivo immunogenicity of Tax(11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccine.

Authors:  Divya Sagar; Shet Masih; Todd Schell; Steven Jacobson; Joseph D Comber; Ramila Philip; Brian Wigdahl; Pooja Jain; Zafar K Khan
Journal:  Vaccine       Date:  2014-04-13       Impact factor: 3.641

9.  Alpha interferon restricts human T-lymphotropic virus type 1 and 2 de novo infection through PKR activation.

Authors:  Anne Cachat; Sébastien Alain Chevalier; Sandrine Alais; Nga Ling Ko; Lee Ratner; Chloé Journo; Hélène Dutartre; Renaud Mahieux
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

10.  Construction and characterization of a full-length infectious simian T-cell lymphotropic virus type 3 molecular clone.

Authors:  Sébastien Alain Chevalier; Marine Walic; Sara Calattini; Adeline Mallet; Marie-Christine Prévost; Antoine Gessain; Renaud Mahieux
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.